{
  "meta": {
    "title": "Pharmacology_Test_1",
    "url": "https://brainandscalpel.vercel.app/pharmacology-test-1-cd0481c2.html",
    "scrapedAt": "2025-11-30T07:33:20.493Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Competitive antagonist</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Inverse agonist</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Partial agonist</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Allosteric modulator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A drug that binds to a receptor at a site distinct from the active site and alters the affinity of the receptor for the endogenous ligand is called as?</span></p>",
      "unique_key": "Q202983",
      "question_audio": null,
      "question_video": null,
      "map_id": 202983,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Allosteric modulators</strong> shows <strong>high selectivity for distinct receptor subtypes. </strong>So they <strong>bind to a receptor at a site distinct from the active site and alters the affinity of the receptor</strong> for the <u>endogenous ligand.</u></p><p>These agents <strong>exert their pharmacological actions by altering the affinity or efficacy of orthosteric muscarinic ligands.</strong></p><p>Positive allosteric modulators <strong>(PAMs) </strong>enhance <strong>orthosteric activity</strong>, while <strong>negative allosteric modulators (NAMs) inhibit it</strong>.</p><p>Allosteric agents that can <strong>directly activate muscarinic receptors</strong> are termed <strong>allosteric agonists.</strong></p><p><strong><u>Option A </u></strong><strong>: </strong><strong>Competitive antagonists</strong> <u>occupy the receptor but do not activate it</u>, while certain drugs are partial agonists which occupy and submaximally activate the receptor</p><p><strong><u>Option B</u></strong><strong>:</strong> <strong>Inverse agonism is manifest only in case of some receptors which show certain degree of Constitutive activation</strong>, i.e. they are partially active even in the basal state (complete absence of any agonist).</p><p><strong><u>Option C</u></strong><strong>:</strong> <strong>Partial agonists also antagonize the effects of a full agonist</strong>, because they occupy a large population of the receptors (while producing small response) and leave fewer receptors to interact with the full agonist.</p><p><strong>[Previous year topic]</strong></p><p><strong>Topic:Allosteric modulator </strong></p><p><strong>Reference:</strong> Goodman &amp; Gilman&rsquo;s The Pharmacological Basis of therapeutics 13<sup>th</sup> edition, page number 150</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Triamterene</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Clarithromycin</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">KCI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36 year old patient with a recent history of heart failure was put on digoxin therapy and had a level of 1 ng/ml on serum level estimation. He was receiving several other drugs and later he presented with flattening of T waves in ECG with raised plasma level of digoxin to 3.8 ng/ml. Which of the following drug is likely to be responsible?</span></p>",
      "unique_key": "Q202984",
      "question_audio": null,
      "question_video": null,
      "map_id": 202984,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>CYP3A4/5 </strong></p><p><strong><em>Carryout biotransformation of largest number (nearly 50%) of drugs. </em></strong></p><p><strong><em>Inhibition of this isoenzyme by erythromycin, clarithromycin, ketoconazole, itraconazole is responsible for the important drug interaction</em></strong> with terfenadine, astemizole and cisapride which are its substrates.</p><p><strong><em>Verapamil, ritonavir and a constituent of grape fruit juice are other important inhibitors.</em></strong></p><ul><li><strong><u>Mnemonic</u></strong></li></ul><p><strong><u>Enzyme inhibitors </u></strong><strong>[ <em>Virat Kohli Can&rsquo;t Call Every Indians</em>]</strong></p><p><strong><u>V</u></strong>alproate</p><p><strong><u>K</u></strong>etoconazole</p><p><strong><u>C</u></strong>imetidine</p><p><strong><u>C</u></strong>iprofloxacin/<strong><u>C</u></strong>larithromycin</p><p><strong><u>E</u></strong>rythromycin</p><p><strong><u>I</u></strong>NH</p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniI10052024/2E.jpg\"><p><strong>[Clinical question]</strong></p><p><strong>Topic: Microsomal enzyme inhibition.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:29</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Vmax</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Km</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in both Km and Vmax</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">No change in Vmax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old male patient brought to ophthalmologist for check up and prescribed a new medicine named Diamox for glaucoma. It is a non-competitive inhibitor of carbonic anhydrase enzyme. Which of the following would be the effect of this drug on following parameters?</span></p>",
      "unique_key": "Q202985",
      "question_audio": null,
      "question_video": null,
      "map_id": 202985,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Enzyme inhibition</strong></p><p>Such inhibition is either <strong>competitive</strong> or <strong>noncompetitive.</strong></p><p><strong>(i) Competitive </strong><em>(equilibrium type) </em>The <strong><em>drug being structurally similar</em></strong> <strong><em>competes with the normal substrate for the catalytic binding site</em></strong> of the enzyme so that the product is not formed or a nonfunctional product is formed,</p><p>Such inhibitors <strong><em>increase the kM</em></strong> but the <strong><em>Vmax </em><em>remains unchanged</em></strong></p><p>A <strong><em>nonequilibrium type </em><em>of enzyme inhibition</em></strong> can also occur with drugs <strong><em>which react with the same catalytic site of the enzyme</em></strong> but either form <strong><u>strong covalent bonds or have such high affinity</u></strong> for the enzyme that the normal substrate is not able to displace the inhibitor</p><p>e.g.</p><ul><li><strong><em>Organophosphates react covalently</em></strong> with the esteretic site of the enzyme cholinesterase.</li></ul><p>In these situations, <strong><em>kM </em><em>is increased and Vmax is reduced.</em></strong></p><p><strong>(ii) Noncompetitive </strong>The <strong><em>inhibitor reacts with an adjacent site</em></strong> and not with the catalytic site, but alters the enzyme in such a way that it loses its catalytic property.</p><p>Thus, <strong><em>kM </em><em>is unchanged but Vmax is reduced</em></strong>.</p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniI10052024/3E.jpg\"><p><strong>[Clinical question]</strong></p><p><strong>Topic: Noncompetitive inhibition</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 47</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">G-protein coupled receptors</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine kinase receptors</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">JAK-STAT receptors</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Ligand-gated guanylyl cyclase receptor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Natriuretic peptide receptors (NPR) belong to which of the following type of receptors?</span></p>",
      "unique_key": "Q202986",
      "question_audio": null,
      "question_video": null,
      "map_id": 202986,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Natriuretic peptide</em></strong> receptors are <strong><em>transmembrane ligand-gated guanylyl cyclase receptor.</em></strong></p><p><strong><u>Natriuretic peptides</u></strong></p><ul><li><strong><em>Atrial natriuretic peptide (ANP):</em></strong> released from <strong><em>atrial storage granules</em></strong> in response to an increase in intravascular volume. It <strong><em>decreases blood pressure.</em></strong></li></ul><ul><li><strong><em>Brain natriuretic peptide (BNP):</em></strong> released from <strong><em>ventricular tissue</em></strong> in response to volume overload. <strong><em>Along with a decrease in blood pressure, it is known to reduce cardiac hypertrophy and fibrosis.</em></strong></li></ul><p><strong><em>C-type natriuretic peptide (CNP</em></strong>) synthesized in the <strong><em>brain and endothelial tissues </em></strong>and functions to <strong><em>stimulate long bone growth</em></strong></p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: Ligand gated receptor.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 59</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">In a clinical setup, efficacy is more important than potency</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">In the log dose response curve, the height of the curve corresponds with efficacy</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">ED50 of the drug corresponds to the efficacy</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Drugs that produce a similar pharmacological effect can have different levels of efficacy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statement is false regarding the efficacy and potency of a drug?</span></p>",
      "unique_key": "Q202987",
      "question_audio": null,
      "question_video": null,
      "map_id": 202987,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Drug potency and efficacy</strong></p><p><strong><em>The position of DRC on the dose axis is the index of drug potency</em></strong> which refers to the <strong><em>amount of drug needed</em></strong> to produce a certain response.</p><p><strong>A DRC positioned<em> rightward</em> indicates <u>lower potency.</u> </strong></p><p><strong><em>Relative potency</em></strong> is often more meaningful than absolute potency, and is generally defined <strong><em>by comparing the dose (concentration) of the two agonists at which they elicit half maximal response (EC50).</em></strong></p><p><strong>Drug potency is clearly a factor in <em><u>choosing the</u></em><u> <em>dose </em>of a drug.</u></strong></p><p><strong><em>The upper limit of DRC is the index of drug efficacy</em></strong> and refers to the <strong><em>maximal </em></strong><strong><em>response</em></strong> that can be elicited by the drug,</p><p><strong><em>Efficacy is a more decisive factor in the <u>choice of a drug.</u></em></strong></p><ul><li><strong><u>Mnemonic (</u></strong><strong><em><u>HELP</u></em></strong><strong><u>)</u></strong></li></ul><p><strong><u>H</u></strong>eight tells about</p><p><strong><u>E</u></strong>fficacy</p><p><strong><u>L</u></strong>eft side drugs are more</p><p><strong><u>P</u></strong>otent</p><p><strong>[Very important question]</strong></p><p><strong>Topic: Dose response curve (DRC).</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 63-64</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Phase I</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Phase II</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Phase III</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Phase IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">\"Proof of concept\" for a new drug is generally proven in which of the following phase of a clinical trial?</span></p>",
      "unique_key": "Q202988",
      "question_audio": null,
      "question_video": null,
      "map_id": 202988,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Phase II </em></strong>is the stage of clinical trials where <strong><em>most of the new drugs</em></strong> will be administered for the first time in <strong><em>patients with the target disease.</em></strong></p><p>It is carried out in a small (50-500) group of patients to obtain <strong><em>&ldquo;proof of concept&rdquo; </em></strong>that the drug has the potential to treat the intended disease. It also includes dose ranging studies with respect to efficacy.</p><p><strong>Phase lla</strong></p><p><strong><em>Proof of concept study</em></strong>: <em>pharmacodynamics or biological activity</em> is the primary endpoint</p><p><strong>Phase Ilb</strong></p><p><strong><em>Dose ranging study</em></strong>: provide inputs for choosing the <em>most appropriate dose for phase III studies</em></p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: phases of Clinical trials. </strong></p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniI10052024/6E.jpg\"><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 91</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">To allay anxiety</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">To decrease secretions</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">As inducing agent</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">For muscle relaxation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45 year old male patient was schedule for surgery. As a part of pre-anaesthetic medication, he was administered glycopyrrolate. What is rationale of giving glycopyrrolate before anaesthesia?</span></p>",
      "unique_key": "Q202989",
      "question_audio": null,
      "question_video": null,
      "map_id": 202989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Preanesthetic medication refers to the use of drugs before anesthesia&nbsp;</em></strong><strong><em>to make it safe and less unpleasant</em></strong>.</li><li>When <strong><em>inhalation anesthetic agents</em></strong> are given, they <em><u>inhibit the ciliary function</u></em> <em>resulting in accumulation of secretions in the respiratory</em> <em>pathway.</em></li><li>Therefore <strong><em>anti-cholinergic drugs like atropine or glycopyrrolate are used as preanesthetic medication for their <u>antisecretory action</u>.</em></strong></li><li><strong><u>Glycopyrrolate</u></strong> is <strong><em>twice as potent and longer acting</em></strong> quaternary antimuscarinic which does <strong><em>not produce central effects.</em></strong></li><li><strong><em>Anti-secretory action is more marked than atropine and tachycardia is less marked.</em></strong></li></ul><p><strong><u>Comparative difference between Atropine &amp; Glycopyrrolate</u></strong></p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniI10052024/7E.jpg\"><p><strong>[Previous year topic]</strong></p><p><strong>Topic: Glycopyrrolate.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 413, 414</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticholinergic</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Sympathomimetic</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Opioid</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 11-year-old child brought to emergency department with history of ingestion of unknown plant and developed mydriasis, tachycardia, dry mouth, warm skin and delirium. Which of the following group of drugs is most likely to be ingested which is responsible for the symptoms of child?</span></p>",
      "unique_key": "Q202990",
      "question_audio": null,
      "question_video": null,
      "map_id": 202990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Mydriasis, tachycardia, dry mouth, warm (hot) skin and delirium are classical symptoms of anticholinergic overdose.</em></strong></p><ul><li><strong><u>Mnemonic</u></strong></li></ul><p><strong>D &ndash; D</strong>ry mouth, <strong>D</strong>elirium</p><p><strong>H &ndash; H</strong>yperthermia</p><p><strong>A &ndash; A</strong>gitation</p><p><strong>T &ndash; T</strong>achycardia</p><p><strong>U &ndash; U</strong>rinary</p><p><strong>R &ndash; R</strong>etention</p><p><strong>A &ndash; A</strong>ccommodation lost (Blurred vision, Photophobia)</p><p><strong><em>Physostigmine is the <u>drug of choice</u> for treatment of atropine and belladona poisoning.</em></strong></p><p><strong>Option B :</strong> <strong><em>Sympathomimetics can cause mydriasis and tachycardia</em></strong>. Delirium is rare and hyperthermia can be seen secondarily to increased agitation and aggressive moments. They are unlikely to present with dry mouth.</p><p><strong>Option C : <em>Opioid overdose results in miosis</em></strong> and other symptoms are not suggestive of opioid overdose</p><p><strong>Option D : <em>Benzodiazepine causes CNS depression</em></strong> and changes in pupil diameter are highly unlikely with its overdose</p><p><strong>[Clinical question]</strong></p><p><strong>Topic: Atropine poisoning </strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 132</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Terazosin</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Silodosin</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxazosin</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 78 year old male patient with history of benign prostatic hyperplasia was initiated with prazosin a week back by his physician. After taking the prescribed medicine, the patient does not want to take the medication because of the severe dizziness which is interfering in his work and patient also had a fainting episode while getting up from the bed. Which of the following can be considered in this patient that can ameliorate the adverse effects?</span></p>",
      "unique_key": "Q202991",
      "question_audio": null,
      "question_video": null,
      "map_id": 202991,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The above patient is experiencing postural hypotension.</p><p><strong><em>Silodosin has a <u>selective antagonist action on alpha 1A receptors</u> over alpha 1B receptors that can help in <u>minimising the postural hypotension</u> and dizziness associated with prazosin.</em></strong></p><p><strong><em>Selective antagonist action on alpha 1A over alpha 1B receptors:</em></strong></p><p>Silodosin</p><p>Tamsulosin</p><p><strong><em>Non-subtype selective alpha 1 receptor antagonists:</em></strong></p><p>Prazosin</p><p>Terazosin</p><p>Doxazosin</p><p>Alfuzosin</p><p><strong>[Clinical question ]</strong></p><p><strong>Topic: Alpha adrenergic blockers</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 156</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Betaxolol</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Latanaprost</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Bimatoprost</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45 year old female patient went for regular eye check up to ophthalmologist and diagnosed of having glaucoma. She was later prescribed some medication for the same. Afterwards she was brought to the casualty with acute bronchial asthma after taking the prescribed treatment for glaucoma. Which of the following is the most probable drug responsible for acute asthmatic attack?</span></p>",
      "unique_key": "Q202992",
      "question_audio": null,
      "question_video": null,
      "map_id": 202992,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Timolol is a non-selective beta blocker</em></strong> that is used in glaucoma.</p><p><strong><em>Non-selective beta-blockers can cause precipitation of bronchial asthma in susceptible individuals</em></strong> (<u>beta 2 blockage on bronchi).</u></p><p><strong><u>Ocular side effects of </u></strong><strong><u>&beta; </u></strong><strong><u>blockers </u></strong></p><p>These are generally mild and infrequent&mdash;stinging, redness and dryness of eye, corneal hypoesthesia, allergic blepharoconjunctivitis and blurred vision.</p><p><strong><u>Systemic adverse effects </u></strong></p><p>These are the <strong><em>major limitations in the use of ocular </em></strong><strong><em>&beta;</em></strong><strong><em> blockers</em></strong>, and occur due to <strong><em>absorption through nasolacrimal duct.</em></strong></p><p><strong><em>Life-threatening bronchospasm</em></strong> has been reported in asthmatic and COPD patients. <strong><em>Bradycardia, accentuation of heart block</em></strong> and CHF are likely to occur, especially in the elderly.</p><p><strong>Option B</strong> : <strong><em>Betaxolol is a beta 1 selective blocker</em></strong> that is used in glaucoma and has <strong><em><u>lower propensity</u> to precipitate bronchial asthma</em></strong>.</p><p><strong>Option C &amp; D</strong> : <strong><em>Latanoprost and bimatoprost are prostaglandin (PGF2 alpha) analogs and <u>does not precipitate</u> bronchial asthma.</em></strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic: Glaucoma_ Anti_ glaucoma drugs.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 167</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Xerostomia</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Blurred vision</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Constipation</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Dyspepsia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34 year old male presented to surgeon with complaints of difficulty in holding urine and increase frequency of urination found to be having overactive bladder disorder. Later he was prescribed muscarinic antagonists for the same. Which of the following is the most common reason for discontinuation of muscarinic antagonists in patients with overactive bladder?</span></p>",
      "unique_key": "Q202993",
      "question_audio": null,
      "question_video": null,
      "map_id": 202993,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Xerostomia is the most common reason for discontinuation of muscarinic antagonists in overactive bladder</em></strong>.</p><p>Most important adverse effects of muscarinic antagonists in overactive bladder are xerostomia, blurred vision, and Gl side effects like constipation and dyspepsia (due to blockage of M1, M2 &amp; M3). Drowsiness, dizziness and confusion can also occur.</p><ul><li><strong><u>Mnemonic</u></strong></li></ul><p><strong>D &ndash; D</strong>ry mouth, <strong>D</strong>elirium</p><p><strong>H &ndash; H</strong>yperthermia</p><p><strong>A &ndash; A</strong>gitation</p><p><strong>T &ndash; T</strong>achycardia</p><p><strong>U &ndash; U</strong>rinary</p><p><strong>R &ndash; R</strong>etention</p><p><strong>A &ndash; A</strong>ccommodation lost (Blurred vision, Photophobia)</p><p><strong>[Clinical question ]</strong></p><p><strong>Topic: Xerostomia due to muscarinic agent.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 131</p>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">High ciliary tone in elderly patients</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticholinergics can precipitate glaucoma</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylephrine can decrease high ciliary tone in elderly patients</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">For which of the following reason Phenylephrine is preferred over other anti-cholinergic agents as a mydriatic agent in elderly patients?</span></p>",
      "unique_key": "Q202994",
      "question_audio": null,
      "question_video": null,
      "map_id": 202994,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>In elderly people, <strong><u>phenylephrine is preferred</u></strong> as mydriatic because <strong><em>anticholinergics can precipitate or aggravate glaucoma by causing relaxation of ciliary body causing mydriasis </em></strong>and altering the forces acting on trabecular meshwork for aqueous outflow.</p><p><strong>[ Previous year topic ]</strong></p><p><strong>Topic _ Phenylephrine _ mydriatic agent.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 131</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Abatacept</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old male presented to rheumatologist with complaints of joint stiffness especially affecting smaller joints with redness since a long time. Later he diagnosed of having rheumatoid arthritis with mild liver function impairment. Which of the following anti-rheumatoid arthritis drug require liver function testing before starting of the treatment?</span></p>",
      "unique_key": "Q202995",
      "question_audio": null,
      "question_video": null,
      "map_id": 202995,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Side effects of Methotrexate</strong></p><p><strong><em>Oral ulceration and gastrointestinal upset</em></strong> are the major side effects of low dose Methotrexate regimen.</p><p>With prolonged therapy, <strong><em>dose dependent progressive liver damage leading to cirrhosis occurs</em></strong> in some patients, while this is not seen with short courses used for cancer. Incidence of chest infection is increased.</p><p><strong><em>Methotrexate is contraindicated in pregnancy, breast-feeding, liver disease, active infection, leucopenia and peptic ulcer.</em></strong></p><p><strong>[Clinical question]</strong></p><p><strong>Topic_ Methotrexate (rheumatoid arthritis).</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 228</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarilumab</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Abatacept</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Golimumab</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Adalimumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67 year old female presented to rheumatologist with complaints of morning joint stiffness especially affecting smaller joints of hands with redness since a long time. Later she diagnosed of having rheumatoid arthritis. Which of the following agent for RA competes with CD28 to prevent full T-cell activation?</span></p>",
      "unique_key": "Q202996",
      "question_audio": null,
      "question_video": null,
      "map_id": 202996,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Abatacept is a <u>costimulation modulator</u> that competes with <u>CD28 </u>to prevent its binding on CD80/CD86 protein, resulting in reduced T-cell activation.</em></strong></p><p><strong>Option C &amp; D</strong>: <strong><em>Golimumab and adalimumab are both TNF-&alpha; inhibitors</em></strong>, and <strong>Option A</strong> : <strong>Sarilumab is an IL-6 inhibitor</strong>.</p><p><strong>[Clinical question]</strong></p><p><strong>Topic_</strong>Abatacept</p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 230</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Febuxostat</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Pegloticase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old man presented to medicine department with history of gout attacks and is found to have an issue with renal excretion of uric acid. Which of the following is the most appropriate drug that would target the cause of his acute gout attacks?</span></p>",
      "unique_key": "Q202997",
      "question_audio": null,
      "question_video": null,
      "map_id": 202997,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Probenecid is a uricosuric agent</em></strong> that increases renal excretion by <strong><em>inhibiting the urate&ndash;anion exchanger in the proximal tubule</em></strong>, thereby blocking <strong><em>reabsorption of uric acid and facilitating its excretion.</em></strong></p><p><strong>Option A &amp; B :</strong> <strong><em>Allopurinol and febuxostat are xanthine oxidase inhibitors</em></strong>, which primarily <strong><em>act by decreasing uric acid production</em></strong>.</p><p><strong>Option D : </strong><strong><em>Pegloticase works by increasing renal excretion of uric acid</em></strong>; however, it is an IV infusion.</p><p><strong>[Previous year topic]</strong></p><p><strong>Topic: Gout</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 232-233</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl salicylic acid is an irreversible inhibitor of the COX enzyme.</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin's clearance is independent of plasma concentration.</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl salicylic acid reduces in vivo synthesis of prostaglandins.</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Antiplatelet effect of low dose aspirin is related to presystemic COX inhibition.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which amongst the following statement is least correct regarding the given NSAIDs?</span></p>",
      "unique_key": "Q202998",
      "question_audio": null,
      "question_video": null,
      "map_id": 202998,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Aspirin is an irreversible inhibitor of the cyclooxygenase (COX) enzyme </em></strong></p><p>Cyclooxygenase synthesizes various prostaglandins from arachidonic acid</p><p><strong><em>Aspirin shows saturation kinetics</em></strong>; at <u>lower plasma concentration</u> aspirin shows <u>first order kinetics</u> and the rate of elimination is proportional to the plasma concentration, whereas at <strong><em>higher plasma concentration zero order kinetics can be seen. </em></strong></p><p><strong><em>Metabolic processes get saturated over the therapeutic range</em></strong>; t&frac12; of antiinflammatory doses may be 8&ndash;12 hours while that during poisoning may be as long as 30 hours. Thus, <strong><em>elimination is dose dependent</em></strong>.</p><p><strong><em>Low dose aspirin acetylates the COX enzyme in the portal circulation</em></strong> (pre systemic) and deactivates it before aspirin is deacetylated in the liver</p><ul><li><strong><u>Mnemonic [Zero WATT Power]</u></strong></li></ul><p><strong>Drugs Following Zero Order Kinetics are</strong></p><p>Zero &rarr; Zero order Kinetics</p><p>W &rarr; Warfarin</p><p>A &rarr; Alcohol/Aspirin</p><p>T &rarr; Theophylline</p><p>T &rarr; Tolbutamide</p><p>Power &rarr; Phenytoin</p><p><strong>[Very important question]</strong></p><p><strong>Topic: Aspirin.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number:214</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis and compensatory renal acidosis</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis and compensatory renal alkalosis</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis and compensatory respiratory acidosis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed respiratory and renal alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 49 year old male patient with history of rheumatoid arthritis was stabilised by his physician on high dose Acetyl salicylic acid. Which of the following is the most appropriate acid-base disturbance caused by a therapeutic dose of Acetyl salicylic acid?</span></p>",
      "unique_key": "Q202999",
      "question_audio": null,
      "question_video": null,
      "map_id": 202999,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Therapeutic doses of aspirin leads to primary respiratory alkalosis and compensatory renal acidosis.</em></strong></p<p><strong><em>Salicylates stimulate respiration indirectly by uncoupling oxidative phosphorylation</em></strong> (increased CO2 levels) and directly by stimulating respiratory centre in medulla.</p><p><strong><em>Respiratory stimulation finally results in fall in PCO2 levels causing respiratory alkalosis</em></strong>. To compensate, bicarbonate ions are increasingly excreted through kidneys and pH is brought to normal. This is the stage of compensated renal acidosis and is seen in the therapeutic range.</p><p><strong>[Clinical question ]</strong></p><p><strong>Topic: Aspirin_adverse drug reactions.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 214</p>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">MAO inhibitors</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Piroxicam</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which amongst the following drug is not considered as hit and run drugs?</span></p>",
      "unique_key": "Q203000",
      "question_audio": null,
      "question_video": null,
      "map_id": 203000,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Hit and run drugs are a group of drugs whose <u>half-life is short</u>, but due to <u>irreversible inhibition of a particular enzyme</u>, the <u>effect of the drug is present even after the drug is cleared from the system</u>.</em></strong></p><p>Piroxicam is a reversible inhibitor of cyclooxygenase enzyme and cannot be considered as a hit and run drug.</p><p><strong>Hit and run drugs:</strong></p><ul><li><strong><u>Mnemonic [MOGRA]</u></strong></li></ul><p><strong>M</strong>AO inhibitors</p><p>PPI like <strong>O</strong>meprazole</p><p><strong>G</strong>uanethidine</p><p><strong>R</strong>eserpine</p><p><strong>A</strong>spirin</p><p><strong>[Very important question]</strong></p><p><strong>Topic: Hit and run drugs.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 42-218</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Dizziness</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Frontal headache</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Vertigo</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old elderly male was prescribed Indomethacin for high grade fever and later followed by significant CNS adverse effects. Which amongst the following is the most frequent CNS adverse effect?</span></p>",
      "unique_key": "Q203001",
      "question_audio": null,
      "question_video": null,
      "map_id": 203001,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The <em>most frequent CNS adverse effect</em> of indomethacin is a <strong><em>severe frontal headache. The incidence is more than 10%.</em></strong></p><p><strong>Gastric ADRs : </strong></p><p><strong><em>Gastric irritation,</em></strong> nausea, anorexia, gastric bleeding and diarrhoea</p><p><strong>CNS ADRs : </strong></p><p><strong><em>Frontal headache (very common),</em></strong> dizziness, ataxia, mental confusion, hallucination, depression and psychosis</p><p><strong><em>Leukopenia, rashes and other hypersensitivity</em></strong></p><p><strong><em>Increased risk of bleeding</em></strong> due to decreased platelet aggregability.</p><p>Indomethacin is <strong><em>contraindicated</em></strong> in machinery operators, drivers, psychiatric patients, epileptics, kidney disease, pregnant women and in children.</p><p><strong>[Very important question]</strong></p><p><strong>Topic_indomethacin.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 219</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorpheniramine Injection</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">High dose corticosterone tablet</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Nebulized salbutamol</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine injection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man was administered penicillin IV. Within 5 minutes of giving penicillin, he developed generalized urticaria, swelling of lips, hypotension, and bronchospasm. Which amongst the following is the most appropriate 1st line drug of choice for him?</span></p>",
      "unique_key": "Q203002",
      "question_audio": null,
      "question_video": null,
      "map_id": 203002,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Generalized urticaria, swelling of lips, hypotension, and bronchospasm suggests that the patient is developing <u>anaphylactic shock.</u></em></strong></p><p><strong><em>Epinephrine injection</em></strong> administered intramuscularly is the <strong><em>preferred choice in anaphylactic shock.</em></strong></p><p><strong><em>Antihistamines have only an adjuvant role</em></strong> in anaphylactic shock</p><p><strong><em>Epinephrine remains the mainstay of the treatment,</em></strong> as autacoids other than histamine are usually involved in anaphylaxis</p><p><strong>[Clinical question]</strong></p><p><strong>Topic_ Epinephrine in anaphylaxis.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 150</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Lansoprazole</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Esomeprazole</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabeprazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old male patient with history of ongoing treatment for tuberculosis presented to medicine department with complaints of heart burn, abdominal fullness, belching and later diagnosed of having Gastroesophageal reflux disease (GERD). Which of the following proton pump inhibitor can be safely given in this patient?</span></p>",
      "unique_key": "Q203003",
      "question_audio": null,
      "question_video": null,
      "map_id": 203003,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Proton pump inhibitors</em></strong> are metabolized by CYP3A4 and <strong><em>CYP2C19</em></strong>.</p><p>They are also <strong><em>inhibitors of these enzymes.</em></strong></p><p><strong><em>Rabeprazole and pantoprazole has less affinity </em></strong>for these enzymes.</p><p><strong>Rabeprazole </strong></p><ul><li>This PPI has <strong><em>faster acid suppression</em></strong>.</li><li>Due to higher pKa, it is more <strong><em>rapidly converted to the active species</em></strong>.</li><li><strong><em>Potency and efficacy are similar to omeprazole</em></strong>.</li><li><strong><em>No significant drug interactions</em></strong></li></ul><p><strong>[Clinical question]</strong></p><p><strong>Topic:Rabeprazole interaction with AKT drugs.</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 701</p>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisacodyl</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Liquid paraffin</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylcellulose</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Bran</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 77-year-old patient presented with weakness, tiredness and muscle cramps. The ECG showed Q-T prolon gation, flattening of T wave and occasional A-V block. His serum K+ was low (2.8 mEq/L). He later admitted taking a laxative every day for the past several months. Which of the following laxative could be responsible for the above condition?</span></p>",
      "unique_key": "Q203004",
      "question_audio": null,
      "question_video": null,
      "map_id": 203004,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Purgative abuse </strong></p><p>Often it is <strong><em>self prescribed</em></strong> and taken without consulting a physician, it may be the <strong><em>reflection of a psychological problem</em></strong>.</p><p><strong><em>Drawbacks of purgative abuse are:</em></strong></p><ol><li><strong>Fluid and electrolyte imbalance</strong>, especially <strong><em>hypokalaemia.</em></strong></li><li>Steatorrhoea, <strong><em>malabsorption syndrome</em></strong>.</li><li><strong><em>Protein losing enteropathy.</em></strong></li><li><strong><em>Spastic colitis</em></strong></li></ol><p><strong>[Clinical question]</strong></p><p><strong>Topic_ purgative (Bisacodyl).</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 726-727</p>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabeprazole</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Pantoprazole</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Lansoprazole</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old female patient with risk developing of deep vein thrombosis (DVT) was started on warfarin. She also had acid peptic disease. Which amongst the following proton-pump inhibitors (PPIs) would be least appropriate for this patient?</span></p>",
      "unique_key": "Q203005",
      "question_audio": null,
      "question_video": null,
      "map_id": 203005,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Omeprazole is not recommended with concomitant use with warfarin as it decreases metabolism of warfarin. </em></strong></p><p>It may also <strong><em>inhibit the metabolism of clopidogrel, warfarin, diazepam, and phenytoin.</em></strong></p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizMay2024/PharmacoMiniI10052024/23E.jpg\"><p><strong><em>Proton pump inhibitors</em></strong> are metabolized by CYP3A4 and <strong><em>CYP2C19</em></strong>.</p><p>They are also <strong><em>inhibitors of these enzymes.</em></strong></p><p><strong><em>Rabeprazole and pantoprazole has less affinity </em></strong>for these enzymes.</p><p><strong>[Previous year topic]</strong></p><p><strong>Topic_ PPIs interactions with warfarin</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number. 701</p>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranitidine combines with sucralfate and prevents its action</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Combination of these 2 drugs produces serious side effects like agranulocytosis</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranitidine increases the gastric pH so sucralfate is not able to act</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucralfate inhibits the absorption of ranitidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old male patient brought to surgical OPD with complaints of acid reflux and burning epigastric pain. Later he was diagnosed of having peptic ulcer and was prescribed ranitidine and sucralfate in the morning hours. Why is this combination incorrect and irrational?</span></p>",
      "unique_key": "Q203006",
      "question_audio": null,
      "question_video": null,
      "map_id": 203006,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><em>Sucralfate polymerizes at a pH&lt;4</em></strong> by crosslinking of the molecules and thus makes a sticky gel- like consistency. It <strong><em>gets adhered to the ulcer base predominantly and remains there for almost 6 hours.</em></strong></p><p>This gel-like consistency keeps the ulcer base from coming in contact with the acid.</p><p>But the <strong><em>polymerization of sucralfate occurs only at an acidic pH</em></strong> and thus <strong><em>concurrent use of H2 blockers like ranitidine increases the gastric pH</em></strong> and thus hinders the polymerization and reduces the efficacy of sucralfate.</p><p><strong>[Previous year topic]</strong></p><p><strong>Topic_ Peptic ulcer drugs</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 704</p>",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Fenofibrate</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Colestipol</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Gemfibrozil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old man with hyperlipidemia and renal insufficiency has been treated with high-intensity atorvastatin for 6 months. His LDL-C is 131 mg/dL; triglycerides, 710 mg/dL; and HDL-C, 32 mg/dL. His physician wishes to add another agent for hyperlipidemia. Which is the best option to address the hyperlipidemia in this patient?</span></p>",
      "unique_key": "Q203007",
      "question_audio": null,
      "question_video": null,
      "map_id": 203007,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This patient has <strong><em>significantly elevated triglycerides and low HDL-C.</em></strong></p><p><strong><em>Niacin can lower triglycerides by 35% to 50% and also raise HDL-C.</em></strong></p><p>The <strong><em>fibrates (fenofibrate and gemfibrozil) should not be used due to the history of renal insufficiency.</em></strong></p><p>In addition, the <strong><em>use of gemfibrozil with statins should be avoided</em></strong>.</p><p><strong>[Clinical question ]</strong></p><p><strong>Topic_ Niacin</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th</sup> edition, page number 689</p>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}